Eculizumab (Anti-Complement C5)
Product Specifications
CAS Number
219685-50-4
Synonyms
Anti-Human C5, Humanized Antibody
Additionnal Information
Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC) . Eculizumab has the potential for haemolysis research. MW: 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1240737-01 0.5 mg (E-Coli)
Recombinant Human cytomegalovirus Protein UL11 (UL11), partial
Sign In for Pricing
View Details MBS1240737-02 0.05 mg (Baculovirus)
Recombinant Human cytomegalovirus Protein UL11 (UL11), partial
Sign In for Pricing
View Details MBS1240737-03 0.5 mg (Yeast)
Recombinant Human cytomegalovirus Protein UL11 (UL11), partial
Sign In for Pricing
View Details MBS1240737-04 0.05 mg (Mammalian-Cell)
Recombinant Human cytomegalovirus Protein UL11 (UL11), partial
Sign In for Pricing
View Details MBS1240737-05 1 mg (E-Coli)
Recombinant Human cytomegalovirus Protein UL11 (UL11), partial
Sign In for Pricing
View Details